BU-NOT-SET

CONTACT US
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
Insight
  • Drug product
Three trends driving small molecule API market growth
Fact sheet
  • Drug product
Vaccine manufacturing
Insight
  • Drug product
Solving the challenges during oral solid dosage development
Insight
  • Drug product
mRNA vaccine manufacturing: how to unlock success
Insight
  • Manufacturing
Pharma packaging trends under the spotlight
Insight
  • Drug product
Modified release formulation and manufacture
Webinar
  • Drug product
Aseptic manufacturing – design of lines for filling and lyophilisation
Case study
  • Drug product
Avoiding pitfalls in sterile manufacturing
Webinar
  • Drug substance
How to develop a cannabinoid into a drug